Marketed products with total annual sales of >US$1 billion, termed ‘blockbusters’, have historically provided the financial basis for most research-based pharmaceutical companies to sustain their innovation-driven research and development (R&D) models. Previous analyses indicated that pharmaceutical companies are increasingly struggling to deliver blockbusters, suggesting that the traditional blockbuster model might […]
pharmaceutical industry functional areas
SK Capital to Acquire Apotex, a Global Leader in Affordable Pharmaceuticals
NEW YORK–(BUSINESS WIRE)–An affiliate of funds advised by SK Capital Partners, LP (“SK Capital”) announced today that it has reached an agreement to acquire Apotex Pharmaceutical Holdings Inc. (“Apotex” or the “Company”), a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines across all major therapeutic areas for patients […]